Skip to content

Drug interactions

Cobimetinib + Ribociclib

Severity: Moderate

Cobimetinib and Ribociclib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cobimetinib is a CYP3A4 substrate, and ribociclib inhibits CYP3A4, so cobimetinib exposure may increase. This may heighten adverse effects such as hemorrhage, rhabdomyolysis, retinopathy and liver toxicity.

What this interaction means in plain words

Cobimetinib and Ribociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cobimetinib belongs to Oncology; Ribociclib belongs to Oncology.

Evidence level: Moderate

Why it happens

Ribociclib inhibition of CYP3A4 reduces cobimetinib metabolism.

What to do

Avoid if alternatives exist; otherwise monitor for cobimetinib toxicity and consider dose reduction.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cobimetinib and Ribociclib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cobimetinib with Ribociclib?

MediHelp rates the interaction as moderate. Cobimetinib and Ribociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cobimetinib is a CYP3A4 substrate, and ribociclib inhibits CYP3A4, so cobimetinib exposure may increase. This may heighten adverse effects such as hemorrhage, rhabdomyolysis, retinopathy and liver toxicity.

How serious is the interaction between Cobimetinib and Ribociclib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if alternatives exist; otherwise monitor for cobimetinib toxicity and consider dose reduction.

What other medicines interact with Ribociclib?

MediHelp also lists interactions of Ribociclib with, for example, Amiodarone, Cisapride, Dofetilide. The full list is on the Ribociclib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in